Kevin Charles Gorman, CEO: Neurocrine Biosciences NBIX Sell · Filed 24/01/10

Trade details

Type: Insider sale
Amount: $14,016,787.4
Shares · price: 105,835 sh · $132.44 a share
Held after: 499,754 sh
Stock: Neurocrine Biosciences NBIX
Person: Kevin Charles GormanCEO
Trade date: 24/01/08
Filed: 24/01/10
Days to filing: 2 days

Sold 17.5% of holdings

Share of holding sold: 17.5%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/12/09~24/02/07

Kevin Charles Gorman's recent trades

Kevin Charles GormanDirector
Sell10b5-1 planXencor
Sell10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
Kevin Charles GormanDirector
Planned sale10b5-1 planXencor
Planned sale10b5-1 plan
Xencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
Kevin Charles GormanDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
Kevin Charles GormanDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07

Kevin Charles Gorman, CEO — sold $14M of Neurocrine Biosciences NBIX · 17.5% of holdings · 10b5-1 plan | Whalegun